164 related articles for article (PubMed ID: 9691832)
1. [Molecular effects of vitamin D on cell cycle and oncogenesis].
Schmidt J; Wittenhagen P; Hørder M
Ugeskr Laeger; 1998 Jul; 160(30):4411-4. PubMed ID: 9691832
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of the selective activity of vitamin D analogues.
Carlberg C
J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
4. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
Nezbedova P; Brtko J
Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
[TBL] [Abstract][Full Text] [Related]
5. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
6. [Biological action mechanisms and effects of calcitriol].
Kveiborg M; Mosekilde L; Eriksen EF; Kassem MS
Ugeskr Laeger; 1999 Oct; 161(41):5669-74. PubMed ID: 10565236
[TBL] [Abstract][Full Text] [Related]
7. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
Pike JW; Pathrose P; Barmina O; Chang CY; McDonnell DP; Yamamoto H; Shevde NK
J Cell Biochem; 2003 Feb; 88(2):252-8. PubMed ID: 12520523
[TBL] [Abstract][Full Text] [Related]
8. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
9. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
Quack M; Clarin A; Binderup E; Björkling F; Hansen CM; Carlberg C
J Cell Biochem; 1998 Dec; 71(3):340-50. PubMed ID: 9831071
[TBL] [Abstract][Full Text] [Related]
10. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements.
Kimmel-Jehan C; Darwish HM; Strugnell SA; Jehan F; Wiefling B; DeLuca HF
J Cell Biochem; 1999 Aug; 74(2):220-8. PubMed ID: 10404392
[TBL] [Abstract][Full Text] [Related]
11. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
[TBL] [Abstract][Full Text] [Related]
12. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.
Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ
Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492
[TBL] [Abstract][Full Text] [Related]
13. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D3 receptor/Sp1 complex is required for the induction of p27Kip1 expression by vitamin D3.
Huang YC; Chen JY; Hung WC
Oncogene; 2004 Jun; 23(28):4856-61. PubMed ID: 15064717
[TBL] [Abstract][Full Text] [Related]
16. All natural DR3-type vitamin D response elements show a similar functionality in vitro.
Toell A; Polly P; Carlberg C
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):301-9. PubMed ID: 11085922
[TBL] [Abstract][Full Text] [Related]
17. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements.
Quack M; Carlberg C
J Mol Biol; 2000 Feb; 296(3):743-56. PubMed ID: 10677278
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D endocrine system and psoriasis vulgaris--review of the literature.
Rucević I; Barisić-Drusko V; Glavas-Obrovac L; Stefanić M
Acta Dermatovenerol Croat; 2009; 17(3):187-92. PubMed ID: 19818218
[TBL] [Abstract][Full Text] [Related]
19. Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor.
Okamura M; Takano Y; Saito Y; Yao J; Kitamura M
Nephrol Dial Transplant; 2009 Oct; 24(10):3006-12. PubMed ID: 19474283
[TBL] [Abstract][Full Text] [Related]
20. The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression.
Larriba MJ; Bonilla F; Muñoz A
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):106-9. PubMed ID: 20138990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]